It's another day in negative territory - the ASX200 closed lower on Wednesday, dropping 0.25% and setting a new 100-day low.
Energy, materials and real estate managed to stay afloat, whilst financials shed nearly 1.2 per cent.
Green
Prescient Therapeutics shot up after securing Orphan Drug Designation in Europe for its lead therapy, PTX-100, targeting cutaneous T-cell lymphoma.
New Frontier Minerals jumped today after announcing that, together with partner Metallium, it now has access to a breakthrough rare-earth processing method. Test work on its Harts Range ore delivered around a 20-fold increase in total rare-earth content in just one step.
Red
DroneShield was down today on news its US CEO, Matt McCrann, has resigned effective immediately.
EML Payments plunged after the company reported a 42% drop in first-quarter underlying EBITDA to $6.8 million. Despite the weaker quarter, management reaffirmed its full-year 2026 EBITDA guidance.
#ASX #ASX200 #AustralianStocks #MarketNews #Investing #Trading #RareEarths #DroneShield #DefenceStocks #Fintech